Progress towards achieving and sustaining maternal and neonatal tetanus elimination--worldwide, 2000-2022/Progres accomplis en vue de realiser et de maintenir l'elimination du tetanos maternel et neonatal dans le monde, 2000-2022

Tetanus remains a significant cause of mortality among undervaccinated mothers and their infants after unhygienic deliveries, especially in low-income countries. The strategies of the maternal and neonatal tetanus elimination (MNTE) initiative, which targets 59 priority countries, include strengthen...

Full description

Saved in:
Bibliographic Details
Published in:Weekly epidemiological record 2024-07, Vol.99 (29), p.381
Main Authors: Jones, Camille E, Yusuf, Nasir, Ahmed, Bilal, Kassogue, Modibo, Wasley, Annemarie, Kanu, Florence A
Format: Article
Language:English
Subjects:
Coronaviruses
Health aspects
Hygiene
Infants (Newborn)
Kenya
Mortality
Nigeria
Pregnant women
Tetanus
Tetanus antitoxin
Vaccination
Vaccines
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tetanus remains a significant cause of mortality among undervaccinated mothers and their infants after unhygienic deliveries, especially in low-income countries. The strategies of the maternal and neonatal tetanus elimination (MNTE) initiative, which targets 59 priority countries, include strengthening antenatal vaccination of pregnant women with tetanus toxoid-containing vaccines (TTCVs), conducting TTCV supplementary immunization activities (SIAs) for women of reproductive age in high-risk districts, optimizing access to skilled birth attendants (SBAs) to ensure clean deliveries and clean umbilical cord care practices and identifying and investigating suspected cases of neonatal tetanus (NT). This report updates a previous report and describes progress towards achieving MNTE during 2000-2022. By December 2022, 47 (80%) of 59 priority countries were validated as having achieved MNTE. In 2022, of the 50 countries that reported coverage with [greater than or equal to]2 doses of TTCV (TTCV2+) among pregnant women, 16 (32%) reported coverage of [greater than or equal to]80%; and, of the 47 validated countries, 26 (55%) reported that [greater than or equal to]70% of births were assisted by SBAs. The number of NT cases reported worldwide decreased by 89%, from 17 935 in 2000 to 1995 in 2021, and the estimated number of deaths due to NT decreased by 84%, from 46 898 to 7719. Global disruption of routine vaccination due to the coronavirus disease 2019 (COVID-19) pandemic, however, slowed progress. Since 2020, the reported number of NT cases has increased in 18 (31%) priority countries. To achieve and sustain global elimination, MNTE strategies should be integrated into countries' national immunization programmes.
ISSN:0049-8114